Zynex (ZYXI) has a profit margin of -68.35%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2025
Trailing 12 months ending Sep 2025
The latest profit margin for ZYXI is -68.35% as of September 2025. That compares with 2.49% in the prior-year period — down 2844.0% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Zynex's historical trend and sector peers before judging valuation or financial health.
Over the past year, ZYXI's profit margin moved from 2.49% to -68.35% — a 2844.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zynex's valuation or profitability profile.
Against Healthcare companies, ZYXI currently prints -68.35% for profit margin, while the sector average sits near 13.89%. That is roughly 592.0% below the sector mean. Large gaps often invite a closer look at Zynex's growth, margins, and balance sheet.
Profit Margin shows how effectively Zynex converts resources into returns. At -68.35%, ZYXI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.49% in the prior-year period — down 2844.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ZYXI's profit margin (-68.35%), review year-over-year change from 2.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.